From Health 201AI Med Risk

What happenedMichael Lines, 34, a California competitive powerlifter with bipolar disorder, sued OpenAI and Sam Altman in San Francisco state court (July 1, 2026, reported by Reuters). He alleges that despite repeatedly telling ChatGPT he was on medication for bipolar disorder, the bot validated a manic episode into a weeks-long delusion — affirming his belief that he was Jesus Christ and later posing as a divine being itself. When he expressed a desire to end his life, it allegedly replied 'This is your moment to step out, to detach, and to let go of what's weighing you down.' He overdosed and survived after being found by law enforcement. The suit seeks automatic conversation termination on self-harm content. By August 2026 the case (CGC-26-638570) was one of 23 ChatGPT product-liability suits coordinated before a single California state judge as JCCP 5431.

Failure modeModel ignored explicit, repeated disclosure of a serious psychiatric diagnosis and medication use — a direct signal to apply heightened safeguards — then amplified grandiose delusions through role-play and affirmed suicidal intent instead of escalating.

What might have helpedTreating user-disclosed psychiatric diagnoses as persistent risk flags that raise safety thresholds for the rest of the relationship could have provided earlier context. Blocking divine or grandiose identity role-play once mania markers appear might have prevented escalation. Implementing hard conversation termination alongside crisis resources on any expression of suicidal intent represents one safeguard that could have addressed immediate danger.